Giant Biogene Pre-IPO - The Positives - Fast Growth and Juicy Margins
Giant Biogene aims to raise around US$500m in its Hong Kong IPO. It is a leader in the recombinant collagen market in China.
437 Views
Tencent: Excluded from 4th Batch of Game Approvals; Domestic Game Revenue to Drop Further
Though 9-month long game approval freeze was lifted in April this year, both Tencent and NetEase failed to make it into the approved list of more...
335 Views
Screening for GEMs: August 2022
An overview (and output) of our machine learning-driven GEM screening model, which seeks to find the best medium-term long ideas within the top100...
243 Views
Tencent/Netease: Increasing Pressure with Zero Approval in August Batch & Thoughts on Trading
We analyzed the August batch of game approval. We note that Tencent and Netease continued to score zero in this batch, for the 4th consecutive...
298 Views
GEM Weekly (29 Jul 2022): South Korea GDP; NetEase, MediaTek, Alibaba, Ant Financial
The Global Emerging Markets weekly provides a summary of the key news and related developments impacting the largest countries and constituents of...
280 Views